Company to educate and guide best practices for maintaining resiliency in the face of increasing ransomware attacks in healthcarePLEASANTON, Calif.,...
Innovative Tech Utilizes AI/ML, IoT/BLE Devices, and Digital WhiteboardsATLANTA, GA / ACCESSWIRE / July 11, 2023 / Vizzia Technologies, a...
Innovative Tech Utilizes AI/ML, IoT/BLE Devices, and Digital WhiteboardsATLANTA, GA / ACCESSWIRE / July 11, 2023 / Vizzia Technologies, a...
CAMBRIDGE, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science...
SAN FRANCISCO, July 11, 2023 (GLOBE NEWSWIRE) -- Artificial intelligence and machine learning innovator McClintock LLC has entered into a...
Vital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetivity Neurosciences' AI CognICA technology poised to play pivotal...
Breakthrough in diagnostics testing enables ‘facial recognition for germs’ Collaboration with John Radcliffe Hospital used AI to identify respiratory viruses...
BOSTON, July 10, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel...
NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- Advanced Health Intelligence Ltd (ASX/NASDAQ:AHI) (“Advanced Health Intelligence”, “AHI” or the “Company”)...
Trial met primary endpoint with the 60 mcg dose, with BXCL501 demonstrating a statistically significant 39% greater reduction in PEC...
Vaccines Investor EventVaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease Sanofi reaffirms ambition to...
BOSTON, June 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel...
Westport, CT, June 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology...
EAGAN, Minn., June 27, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence...
Anavex and Partex agreed to enter into a strategic partnership to leverage Partex’s proprietary AI (Artificial Intelligence) technology for Anavex’s...
BOSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel...
Patent EP 3 332 028 B1 granted by the European Patent Office covers the identification and use of genomic variants...
Interventional study to evaluate long term outcomes of Volta’s AI solution-supported ablation in recurrent-AF patients who failed previous ablationInternational, multi-center...
Video Represents Latest in the Company’s “Director’s Forum” Series – Observations from the Company’s Independent DirectorsMIAMI, June 21, 2023 (GLOBE...
With millions of Americans experiencing mental health symptoms, 23andMe+ members now have exclusive access to four mental health reports to...